Your browser doesn't support javascript.
loading
Developmental epileptic encephalopathy in DLG4-related synaptopathy.
Kassabian, Benedetta; Levy, Amanda M; Gardella, Elena; Aledo-Serrano, Angel; Ananth, Amitha L; Brea-Fernández, Alejandro J; Caumes, Roseline; Chatron, Nicolas; Dainelli, Alice; De Wachter, Matthias; Denommé-Pichon, Anne-Sophie; Dye, Thomas J; Fazzi, Elisa; Felt, Roxanne; Fernández-Jaén, Alberto; Fernández-Prieto, Montse; Gantz, Emily; Gasperowicz, Piotr; Gil-Nagel, Antonio; Gómez-Andrés, David; Greiner, Hansel M; Guerrini, Renzo; Haanpää, Maria K; Helin, Minttu; Hoyer, Juliane; Hurst, Anna C E; Kallish, Staci; Karkare, Shefali N; Khan, Amjad; Kleinendorst, Lotte; Koch, Johannes; Kothare, Sanjeev V; Koudijs, Suzanna M; Lagae, Lieven; Lakeman, Phillis; Leppig, Kathleen A; Lesca, Gaetan; Lopergolo, Diego; Lusk, Laina; Mackenzie, Alex; Mei, Davide; Møller, Rikke S; Pereira, Elaine M; Platzer, Konrad; Quelin, Chloe; Revah-Politi, Anya; Rheims, Sylvain; Rodríguez-Palmero, Agustí; Rossi, Andrea; Santorelli, Filippo.
Afiliação
  • Kassabian B; Department of Epilepsy Genetics and Precision Medicine, Danish Epilepsy Center Filadelfia, member of the European Reference Network EpiCARE, Dianalund, Denmark.
  • Levy AM; Neurology Unit, Department of Neurosciences, University of Padua, Padua, Italy.
  • Gardella E; Department of Clinical Genetics, Kennedy Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Aledo-Serrano A; Department of Epilepsy Genetics and Precision Medicine, Danish Epilepsy Center Filadelfia, member of the European Reference Network EpiCARE, Dianalund, Denmark.
  • Ananth AL; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Brea-Fernández AJ; Epilepsy and Neurogenetics Unit, Vithas la Milagrosa University Hospital, Vithas Hospital Group, Madrid, Spain.
  • Caumes R; Division of Pediatric Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Chatron N; Grupo de Genómica y Bioinformática, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Centro de Investigación Biomédica en Red de Enfermedades Raras del Instituto de Salud Carlos III (CIBERER-ISCIII), Universidade de Santiago de Compostela, Santiago de Compostel
  • Dainelli A; Grupo de Genética, Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Biomédica de Santiago (IDIS), Santiago de Compostela, Spain.
  • De Wachter M; CHU de Lille, Clinique de Génétique, Lille, France.
  • Denommé-Pichon AS; Service de Genetique, Hospices Civils de Lyon, Bron, France.
  • Dye TJ; Institute NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, Centre National de la recherche scientifique (CNRS) Unité mixte de recherche (UMR) 5261- L'Institut national de la santé et de la recherche médicale (INSERM) U1315, Université de Lyon-Université Claude Bernard
  • Fazzi E; Neuroscience Department, Meyer Children's Hospital IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), member of the European Reference Network EpiCARE, Florence, Italy.
  • Felt R; Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
  • Fernández-Jaén A; Functional Unit for Diagnostic Innovation in Rare Diseases, Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement (FHU-TRANSLAD), Dijon Bourgogne University Hospital, Dijon, France.
  • Fernández-Prieto M; L'Institut national de la santé et de la recherche médicale (INSERM) Unité mixte de recherche (UMR) 1231, Génétique des Anomalies du Développement (GAD), Fédération Hospitalo-Universitaire Médecine TRANSLationnelle et Anomalies du Développement (FHU-TRANSLAD), University of Burgundy, Dijon, France.
  • Gantz E; Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Gasperowicz P; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Gil-Nagel A; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Gómez-Andrés D; Unit of Child Neurology and Psychiatry, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili of Brescia, Brescia, Italy.
  • Greiner HM; Department of Neurology, Kaiser Permanente Bellevue Medical Center, Bellevue, Washington, USA.
  • Guerrini R; Department of Pediatric Neurology, Neurogenetics Section, Hospital Universitario Quirónsalud, Madrid, Spain.
  • Haanpää MK; Facultad de Medicina, Universidad Europea, Madrid, Spain.
  • Helin M; Grupo de Genómica y Bioinformática, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Centro de Investigación Biomédica en Red de Enfermedades Raras del Instituto de Salud Carlos III (CIBERER-ISCIII), Universidade de Santiago de Compostela, Santiago de Compostel
  • Hoyer J; Grupo de Genética, Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Biomédica de Santiago (IDIS), Santiago de Compostela, Spain.
  • Hurst ACE; Division of Pediatric Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Kallish S; Department of Medical Genetics, Medical University of Warsaw, Warsaw, Poland.
  • Karkare SN; Neurology Department, Epilepsy Program, Ruber Internacional Hospital, Madrid, Spain.
  • Khan A; Child Neurology Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Kleinendorst L; Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Koch J; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Kothare SV; Neuroscience Department, Meyer Children's Hospital IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), member of the European Reference Network EpiCARE, Florence, Italy.
  • Koudijs SM; Department of Genomics, Turku University Hospital, Turku, Finland.
  • Lagae L; Department of Pediatric Neurology, Turku University Hospital, Turku, Finland.
  • Lakeman P; Friedrich-Alexander-Universität Erlangen Nürnberg, Institute of Human Genetics, Erlangen, Germany.
  • Leppig KA; Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Lesca G; Division of Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Lopergolo D; Division of Pediatric Neurology, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, New York, USA.
  • Lusk L; Department of Zoology, Faculty of Biological Sciences, University of Lakki Marwat, Lakki Marwat, Pakistan.
  • Mackenzie A; Institute for Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
  • Mei D; Department of Human Genetics, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, the Netherlands.
  • Møller RS; Emma Center for Personalized Medicine, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, the Netherlands.
  • Pereira EM; University Children's Hospital, Paracelsus Medical University, Salzburg, Austria.
  • Platzer K; Division of Pediatric Neurology, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, New York, USA.
  • Quelin C; Department of Neurology, Erasmus Medical Center (MC) Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Revah-Politi A; Erfelijke Neuro-Cognitieve Ontwikkelingsstoornissen, Rotterdam, Erasmus Medical Center (ENCORE)-GRIN Expertise Center, Rotterdam, the Netherlands.
  • Rheims S; Department of Development and Regeneration, Section Paediatric Neurology, member of the European Reference Network EpiCARE, University Hospitals Leuven, Leuven, Belgium.
  • Rodríguez-Palmero A; Department of Human Genetics, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, the Netherlands.
  • Rossi A; Genetic Services, Kaiser Permanente of Washington, Seattle, Washington, USA.
  • Santorelli F; Service de Genetique, Hospices Civils de Lyon, Bron, France.
Epilepsia ; 65(4): 1029-1045, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38135915
ABSTRACT

OBJECTIVE:

The postsynaptic density protein of excitatory neurons PSD-95 is encoded by discs large MAGUK scaffold protein 4 (DLG4), de novo pathogenic variants of which lead to DLG4-related synaptopathy. The major clinical features are developmental delay, intellectual disability (ID), hypotonia, sleep disturbances, movement disorders, and epilepsy. Even though epilepsy is present in 50% of the individuals, it has not been investigated in detail. We describe here the phenotypic spectrum of epilepsy and associated comorbidities in patients with DLG4-related synaptopathy.

METHODS:

We included 35 individuals with a DLG4 variant and epilepsy as part of a multicenter study. The DLG4 variants were detected by the referring laboratories. The degree of ID, hypotonia, developmental delay, and motor disturbances were evaluated by the referring clinician. Data on awake and sleep electroencephalography (EEG) and/or video-polygraphy and brain magnetic resonance imaging were collected. Antiseizure medication response was retrospectively assessed by the referring clinician.

RESULTS:

A large variety of seizure types was reported, although focal seizures were the most common. Encephalopathy related to status epilepticus during slow-wave sleep (ESES)/developmental epileptic encephalopathy with spike-wave activation during sleep (DEE-SWAS) was diagnosed in >25% of the individuals. All but one individual presented with neurodevelopmental delay. Regression in verbal and/or motor domains was observed in all individuals who suffered from ESES/DEE-SWAS, as well as some who did not. We could not identify a clear genotype-phenotype relationship even between individuals with the same DLG4 variants.

SIGNIFICANCE:

Our study shows that a subgroup of individuals with DLG4-related synaptopathy have DEE, and approximately one fourth of them have ESES/DEE-SWAS. Our study confirms DEE as part of the DLG4-related phenotypic spectrum. Occurrence of ESES/DEE-SWAS in DLG4-related synaptopathy requires proper investigation with sleep EEG.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatias / Epilepsia Generalizada / Epilepsia / Deficiência Intelectual Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatias / Epilepsia Generalizada / Epilepsia / Deficiência Intelectual Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article